Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Funding for innovative projects in the field of non-alcoholic steatohepatitis (NASH).
Característiques principals
The ASPIRE NASH program will evaluate submitted research proposals that cover areas in basic, clinical and translational sciences. The research proposals with innovative and the potential of high impact in advancing the learning about NASH will be encouraged.

The followings are the main areas of priority with high unmet needs:
  • Biopsy-confirmed NASH prevalence, clinical outcomes, and healthcare utilization
  • Innovations in the use of non-invasive tools in the care of patients with NASH
  • Understanding genetic drivers of NASH and identification of fast progressors

    Out of scope research includes:
  • Studies involving investigational products
  • Studies comparing a competitor drug vs. a Pfizer product
  • Highly invasive studies and studies that may have an ethical concern
  • Mere replication of existing studies (i.e., lack of innovation)
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
    Marta López: mlopez4@imim.es Ext.: 1576
    Carol Barnwell: cbarnwell@imim.es Ext.1670
    Convocatòria (URL)
    https://cdn.pfizer.com/pfizercom/2022-09/GMG_20222023-IM-G_NASHASPIRE.pdf?7hII28k3lQwFOBfORRMClofo17PDqKf
    Requisits
  • Only organizations are eligible to receive grants, not individuals or medical practice groups.
  • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
  • Applicant must be affiliated with a host institution.
  • Both early career and experienced investigators are encouraged to apply and consideration will be given to all proposals meeting the selection criteria
    • Dotació
    Up to $140,000
    Durada
    2-3 years.
    Documentació
    Proposals should be submitted at: www.cybergrants.com/pfizer/loi
    AVÍS IMPORTANT
    Letter of Intent (LOI) due date: October 20, 2022
    Full Proposal Deadline: March 2023
    Only accepted LOIs will be invited to submit full proposals

    Arxius

    Arxiu
    GMG_20222023-IM-G_NASHASPIRE.pdf